4-carbamoyl-5-amino-1-<(2-hydroxyethoxy)methyl>imidazole | 77856-29-2

• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 羧酸及其衍生物
• 英文名称: 4-carbamoyl-5-amino-1-<(2-hydroxyethoxy)methyl>imidazole
• 英文别名: 5-Amino-4-carbamoyl-1-(2-hydroxyethoxymethyl)imidazole；5-amino-1-<(2-hydroxyethoxy)methyl>imidazole-4-carboxaminde；5-amino-1-<(2-hydroxyethoxy)methyl>-1H-imidazole-4-carboxamide；5-Amino-1-(2-hydroxyethoxymethyl)imidazole-4-carboxamide
• CAS: 77856-29-2
• 化学式: C₇H₁₂N₄O₃
• 分子量: 200.197
• InChiKey: QDSZRSNZYMOQCL-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  -1.4
• 重原子数：
  14
• 可旋转键数：
  5
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.43
• 拓扑面积：
  116
• 氢给体数：
  3
• 氢受体数：
  5

反应信息

• 作为产物：
  描述：

  5-amino-1-<<2-(acetyloxy)ethoxy>methyl>-1H-imidazole-4-carboxamide 在 ammonium hydroxide 作用下， 以 乙醇 为溶剂， 反应 65.0h， 以90%的产率得到4-carbamoyl-5-amino-1-<(2-hydroxyethoxy)methyl>imidazole
  参考文献：
  名称：

  A simple and efficient synthesis of 9-substituted guanines. Cyclodesulfurization of 1-substituted 5-[(thiocarbamoyl)amino]imidazole-4-carboxamides under aqueous basic conditions

  摘要：

  5-Aminoimidazole-4-carboxamide (AICA) (1a) is 1-alkylated by an improved method. The resulting 5-amino-1-alkylimidazole-4-carboxamides (1b-i) are converted to the corresponding 1-alkyl-5-[(thiocarbamoyl)-amino]imidazole-4-carboxamides (3). These compounds are ring closed under alkaline conditions to 9-substituted guanines (5) in very high yields by treatment with heavy-metal salts in aqueous sodium hydroxide, or, in somewhat lower yields, by S-oxidation with hydrogen peroxide or sodium perborate in aqueous sodium hydroxide.

  DOI：

  10.1021/jo00006a033

文献信息

• Synthesis and pharmacological evaluation of a series of analogs of 1-methylisoguanosine
  作者：Robert T. Bartlett、Alan F. Cook、Michael J. Holman、Warren W. McComas、Eugene F. Nowoswait、Mohindar S. Poonian、Judy A. Baird-Lambert、Brian A. Baldo、John F. Marwood

  DOI：10.1021/jm00140a007

  日期：1981.8

  Modification at the 5' position yielded the deoxy, iodo, and phosphate derivatives 15, 13, and 16, as well as the cyclic 3',5'-phosphate 17. The synthesis of the C-nucleoside analogue 19 was achieved from the beta-D-ribofuranosylcarboximidic ester 20. The acyclic analogue 29 and the beta-D-arabinofuranosyl derivative 35 were both synthesized by reaction of methyl isocyanate with the appropriately protected

  在肌肉松弛剂，心血管，抗炎和抗过敏试验中，评估了具有药理活性的海洋天然产物1-甲基异鸟苷（1）的一系列类似物的生物活性。在1位上的修饰分别产生乙基，正丁基，正辛基和苯基衍生物3-6。在8位的取代提供了溴，肼和氨基化合物9-11。在5'位的修饰产生了脱氧，碘和磷酸盐衍生物15、13和16，以及环状3'，5'-磷酸盐17。C-核苷类似物19的合成由β完成-D-呋喃核糖基羧酰亚胺酯20。无环类似物29和β-D-阿拉伯呋喃糖基衍生物35都是通过异氰酸甲酯与适当保护的氨基氰咪唑前体28和32反应合成的。1-甲基黄嘌呤（12），异鸟苷（7）和2-甲氧基腺苷（18）。也被合成。在高达100 mg / kg po的剂量下，5'-磷酸16，环状3'，5'-磷酸17和O-甲基化的类似物2-甲氧基腺苷18在产生肌肉松弛和体温过低方面具有活性。这些化合物具有抗过敏活性，并且与1-乙基（3）和1-正丁基（4）类似物
• Acyclic analogues of purine and imidazole nucleosides
  作者：Ann Parkin、Michael R. Harnden

  DOI：10.1002/jhet.5570190104

  日期：1982.1

  Hydroxyl-protected derivatives of 1- and 3-(2-hydroxyethoxymethyl)imidazoles (4,5,7-10) have been prepared from 5-amino-4-carbamoylimidazoles (2). The protected derivatives were converted to acyclic analogues of imidazole nucleosides (6) or subjected to various cyclisation reactions leading to 9-(2-hydroxy-ethoxymethyl)-substituted 2-methyl-, 2-phenyl- and 2-azahypoxanthines (18,13 and 20, respectively)

  的1-和3-（2-羟基乙氧基甲基）咪唑（羟基被保护的衍生物4,5,7-10）已经从5-氨基-4- carbamoylimidazoles（制备2）。将受保护的衍生物转化为咪唑核苷的无环类似物（6）或进行各种环化反应，生成9-（2-羟基-乙氧基甲基）取代的2-甲基-，2-苯基-和2-氮杂泛黄嘌呤（18,13和分别为20和1-甲基鸟嘌呤（28）。为了将结构分配给异构的咪唑和嘌呤衍生物，已使用13 C化学位移。
• Modifications on the heterocyclic base of acyclovir: syntheses and antiviral properties
  作者：Lilia M. Beauchamp、Bart L. Dolmatch、Howard J. Schaeffer、Peter Collins、D. J. Bauer、Paul M. Keller、James A. Fyfe

  DOI：10.1021/jm00146a002

  日期：1985.8

  A group of compounds was prepared in which variations of the ring portion of the acyclovir (ACV) structure were made. These modifications included monocyclic (isocytosine, triazole, imidazole), bicyclic (8-azapurine, pyrrolo[2,3-d]pyrimidine, pyrazolo[3,4-d]pyrimidine) and tricyclic (linear benzoguanine) congeners. The derivatives were evaluated against herpes simplex virus type 1 (HSV-1) by the plaque-inhibition and plaque-reduction methods with only the 8-azapurine analogue 28 showing some activity. In a test measuring the ability of these compounds to inhibit the HSV-1 thymidine kinase, 28 and the tricyclic derivative 38 exhibited competition with ACV for binding to the enzyme. The inability of the group to exert significant antiherpetic action is attributed to their lack of phosphorylation to the requisite triphosphate stage.
• ALNEDE, VZHUSTORGE;SLAUSEN, FINN PRIESS;JUHL-CHRISTENSEN, JZHUSTORGEN;MSS+, J. ORG. CHEM., 56,(1991) N, C. 2139-2143
  作者：ALNEDE, VZHUSTORGE、SLAUSEN, FINN PRIESS、JUHL-CHRISTENSEN, JZHUSTORGEN、MSS+

  DOI：——

  日期：——